Standardized guidelines for acral and nail unit melanoma treatment are lacking
- PMID: 35988843
- DOI: 10.1016/j.jaad.2022.08.024
Standardized guidelines for acral and nail unit melanoma treatment are lacking
Conflict of interest statement
Conflicts of interest Ms Falotico has no conflicts of interest. Dr Postow serves as a consultant for BMS, Merck, Array BioPharma, Novartis, Incyte, NewLink Genetics, Aduro, Eisai, and Pfizer and receives institutional support from RGenix, Infinity, BMS, Merck, Array BioPharma, Novartis, and AstraZeneca. Dr Lipner has served as a consultant for Ortho Dermatologics, Verrica, Hoth Therapeutics, BelleTorus Corporation, and Hexima.
Comment on
-
Melanoma: An update on systemic therapies.J Am Acad Dermatol. 2022 Mar;86(3):515-524. doi: 10.1016/j.jaad.2021.09.075. Epub 2021 Dec 13. J Am Acad Dermatol. 2022. PMID: 34915056 Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
